-+ 0.00%
-+ 0.00%
-+ 0.00%

PASITHEA THERAPEUTICS CORP - PHASE 2 STUDY OF PAS-004 TO BE CONDUCTED UNDER ACTIVE IND OVERSEEN BY FDA DDD

Reuters·11/03/2026 12:00:00

Please log in to view news